Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Item No. 39151

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
8-Methoxymethyl-3-isobutyl-1-methylxanthine is an inhibitor of phosphodiesterase 1 (PDE1; IC50 = 5 µM) and a derivative of IBMX (Item No. 13347).1 It is selective for PDE1 over PDE2, PDE3, and PDE4 but also inhibits PDE5 (IC50s = 37, >400, >400, and 2 µM, respectively). 8-Methoxymethyl-3-isobutyl-1-methylxanthine (30 µM) enhances forskolin-induced increases in intracellular calcium levels in isolated rat olfactory receptor neurons.2 It induces relaxation of isolated human saphenous vein segments in the absence of endothelium (EC50 = 31 µM).3 In vivo, 8-methoxymethyl-3-isobutyl-1-methylxanthine (200 µg/kg) enhances decreases in pulmonary artery pressure and vascular resistance induced by iloprost (Item No. 18215) in a rabbit model of pulmonary hypertension induced by the TP receptor agonist U-46619 (Item No. 16450).4
WARNING This product is not for human or veterinary use.
1. Cyclic AMP-
2. Characterization of forskolin-
3. The flavonoid dioclein is a selective inhibitor of cyclic nucleotide phosphodiesterase type 1 (PDE1) and a cGMP-
4. Lung vasodilatory response to inhaled iloprost in experimental pulmonary hypertension: Amplification by different type phosphodiesterase inhibitors. Respir. Res. 6(1), 76 (2005).